secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2024-08-08T23:59:59+00:00
Accession:  0001437749-24-025565
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris issues special voting preferred to Chairman to secure authorized share increase vote
--------------------------------------------------------------------------------

- Issued 1 share of Series F Preferred to Chairman James Geraghty for $1 cash; preferred has 25M votes.
- Preferred votes only on proposal to increase authorized common shares, in proportion to common votes.
- No conversion, dividends, or liquidation rights; redeemable for $0.01 upon authorized share increase or Board order.
- The authorized share increase is to facilitate the proposed merger with Palvella Therapeutics.
- The preferred ensures a favorable vote on the authorized share increase, a key step in the merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924025565/0001437749-24-025565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924025565/pirs20240807_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-025565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer